Cover Image

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemias are the most common malignancies in childhood. Although its etiology is still unclear, it is thought that disorders in oxidative stress metabolism may contribute to leukemogenesis. Advanced glycation end products (AGEs) are formed as a result of the non-enzymatic bindin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Busra Ozkan (Author), Yasemin Altuner Torun (Author), Cigdem Karakukcu (Author), Binnaz Celik (Author)
Format:	Book
Published:	MDPI AG, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
by: Elena Dozio, et al.
Published: (2018)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022)

Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women
by: Nabigh A NAJI, et al.
Published: (2021)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021)

Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease
by: Kelly N. Z. Fuller, et al.
Published: (2018)

Association between Preoperative Plasma sRAGE Levels and Recovery from Cardiac Surgery
by: Benedict C. Creagh-Brown, et al.
Published: (2013)

High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma
by: Jason T. Patregnani, et al.
Published: (2020)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021)

An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer
by: Jihui Zheng, et al.
Published: (2021)

Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT
by: Colomba Falcone, et al.
Published: (2012)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
by: Hiromi Abe, et al.
Published: (2023)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020)

The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals
by: Karen Ingrid Tasca, et al.
Published: (2016)

Assessment of Oxidative Stress and Plasma Gelsolin Levels in Children with IgA Vasculitis
by: Burcu Danacı, et al.
Published: (2024)

Relationship between sRAGE and hsCRP as Markers of Cardiovascular Disease Risk Factors in Diabetic and Non-Diabetic Men with Central Obesity
by: Rambu Beppy Hamuaty, et al.
Published: (2017)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
by: Heliang Liu, et al.
Published: (2020)

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
by: Jae Wook Lee, et al.
Published: (2017)

Survival and prognostic factors of childhood acute lymphoblastic leukemia
by: Emelyana Permatasari, et al.
Published: (2009)

AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers
by: Gowri Palanissami, et al.
Published: (2023)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
by: William H. Hoffman, et al.
Published: (2020)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
by: Theodor Asgeirsson, et al.
Published: (2011)

A systematic review and meta-analysis of the relationship between advanced glycation end products ceceptor (RAGE) gene polymorphisms and the risk of inflammatory bowel disease
by: Ratih Puspita Febrinasari, et al.
Published: (2023)

Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
by: Maria Ferraro, et al.
Published: (2022)

Soluble Receptor for Advanced Glycation End Products: A Novel Biomarker for Psoriasis Severity with Therapeutic Implications?
by: Aleksandra Batycka-Baran, et al.
Published: (2018)

Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
by: Chan Ho Kim, et al.
Published: (2023)

Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns
by: Hayato Go, et al.
Published: (2021)

RAGE receptor and its soluble isoforms in diabetes mellitus complications
by: Mauren Isfer Anghebem Oliveira, et al.
Published: (2013)

CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction
by: Govigerel Bayarsaikhan, et al.
Published: (2021)

Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
by: Elena Dozio, et al.
Published: (2017)

Rhodotorula fungemia in a patient with acute lymphoblastic leukemia
by: Mehmet Erinmez, et al.
Published: (2022)

Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome
by: Neda Emami, et al.
Published: (2023)

Can CD34+CD38− lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?
by: Weronika Stolpa, et al.
Published: (2023)

Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters
by: Xi Yang, et al.
Published: (2024)

Exhaled phospholipids as a prognostic factor of pulmonary complications in children with acute lymphoblastic leukemia
by: N.I. Makieieva, et al.
Published: (2023)

Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model
by: Hyun-Jin Tae, DVM, PhD, et al.
Published: (2014)

Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
by: Elena Dozio, et al.
Published: (2019)

Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease
by: Steven K. Malin, et al.
Published: (2020)

Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury
by: Yasuhisa Izushi, et al.
Published: (2016)

Treatment of acute lymphoblastic leukemia with protocol Hongkong-Indonesia Acute Lymphoblastic Leukemia 97
by: Johannes Bondan Lukito
Published: (2007)